REPORT ID 4124

United States Bioresorbable Coronary Stents Market Report 2017

Publish Date
15-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the United States Bioresorbable Coronary Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Bioresorbable Coronary Stents in these regions, from 2012 to 2022 (forecast).

United States Bioresorbable Coronary Stents market competition by top manufacturers/players, with Bioresorbable Coronary Stents sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    BIOTRONIK
    Meril Lifesciences Pvt. Ltd.
    Elixir Medical Corporation
    REVA Medical
    Arterial Remodeling Technologies
    Amaranth Medical
    Microport Scientific Corporation
    Arterius

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Absorb BVS
    Absorb 2nd?Generation
    Magmaris
    Magnitude
    MeRes-100
    DESolve
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Research Institute

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Bioresorbable Coronary Stents Market Report 2017
1 Bioresorbable Coronary Stents Overview
    1.1 Product Overview and Scope of Bioresorbable Coronary Stents
    1.2 Classification of Bioresorbable Coronary Stents by Product Category
        1.2.1 United States Bioresorbable Coronary Stents Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Bioresorbable Coronary Stents Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Absorb BVS
        1.2.4 Absorb 2nd?Generation
        1.2.5 Magmaris
        1.2.6 Magnitude
        1.2.7 MeRes-100
        1.2.8 DESolve
    1.3 United States Bioresorbable Coronary Stents Market by Application/End Users
        1.3.1 United States Bioresorbable Coronary Stents Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Research Institute
    1.4 United States Bioresorbable Coronary Stents Market by Region
        1.4.1 United States Bioresorbable Coronary Stents Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Bioresorbable Coronary Stents Status and Prospect (2012-2022)
        1.4.3 Southwest Bioresorbable Coronary Stents Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Bioresorbable Coronary Stents Status and Prospect (2012-2022)
        1.4.5 New England Bioresorbable Coronary Stents Status and Prospect (2012-2022)
        1.4.6 The South Bioresorbable Coronary Stents Status and Prospect (2012-2022)
        1.4.7 The Midwest Bioresorbable Coronary Stents Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Bioresorbable Coronary Stents (2012-2022)
        1.5.1 United States Bioresorbable Coronary Stents Sales and Growth Rate (2012-2022)
        1.5.2 United States Bioresorbable Coronary Stents Revenue and Growth Rate (2012-2022)

2 United States Bioresorbable Coronary Stents Market Competition by Players/Suppliers
    2.1 United States Bioresorbable Coronary Stents Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Bioresorbable Coronary Stents Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Bioresorbable Coronary Stents Average Price by Players/Suppliers (2012-2017)
    2.4 United States Bioresorbable Coronary Stents Market Competitive Situation and Trends
        2.4.1 United States Bioresorbable Coronary Stents Market Concentration Rate
        2.4.2 United States Bioresorbable Coronary Stents Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Bioresorbable Coronary Stents Manufacturing Base Distribution, Sales Area, Product Type

3 United States Bioresorbable Coronary Stents Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Bioresorbable Coronary Stents Sales and Market Share by Region (2012-2017)
    3.2 United States Bioresorbable Coronary Stents Revenue and Market Share by Region (2012-2017)
    3.3 United States Bioresorbable Coronary Stents Price by Region (2012-2017)

4 United States Bioresorbable Coronary Stents Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Bioresorbable Coronary Stents Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Bioresorbable Coronary Stents Revenue and Market Share by Type (2012-2017)
    4.3 United States Bioresorbable Coronary Stents Price by Type (2012-2017)
    4.4 United States Bioresorbable Coronary Stents Sales Growth Rate by Type (2012-2017)

5 United States Bioresorbable Coronary Stents Sales (Volume) by Application (2012-2017)
    5.1 United States Bioresorbable Coronary Stents Sales and Market Share by Application (2012-2017)
    5.2 United States Bioresorbable Coronary Stents Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Bioresorbable Coronary Stents Players/Suppliers Profiles and Sales Data
    6.1 BIOTRONIK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 BIOTRONIK Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Meril Lifesciences Pvt. Ltd.
        6.2.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Meril Lifesciences Pvt. Ltd. Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Elixir Medical Corporation
        6.3.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Elixir Medical Corporation Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 REVA Medical
        6.4.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 REVA Medical Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Arterial Remodeling Technologies
        6.5.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Arterial Remodeling Technologies Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Amaranth Medical
        6.6.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Amaranth Medical Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Microport Scientific Corporation
        6.7.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Microport Scientific Corporation Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Arterius
        6.8.2 Bioresorbable Coronary Stents Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Arterius Bioresorbable Coronary Stents Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Bioresorbable Coronary Stents Manufacturing Cost Analysis
    7.1 Bioresorbable Coronary Stents Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Bioresorbable Coronary Stents

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Bioresorbable Coronary Stents Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Bioresorbable Coronary Stents Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Bioresorbable Coronary Stents Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Bioresorbable Coronary Stents Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Bioresorbable Coronary Stents Sales Volume Forecast by Type (2017-2022)
    11.3 United States Bioresorbable Coronary Stents Sales Volume Forecast by Application (2017-2022)
    11.4 United States Bioresorbable Coronary Stents Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer